Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study on Tocilizumab in Patients with Predicted Severe Acute Pancreatitis (STOP-SAP)
TCTR20210302008Phase 3Not yet recruiting
- Sponsor
- Chulalongkorn University
- Start
- Mar 2021
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in acute pancreatitis (AP) comparing Tocilizumab arm with Placebo arm (2 arms). Planned start Mar 2021; status: not yet recruiting.
02
Drugs
tocilizumab
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on TCTR20210302008.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210302008.